Surrozen (SRZN) Change in Accured Expenses (2020 - 2026)

Surrozen (SRZN) recorded quarterly Change in Accured Expenses of -$1.2 million in Q1 2026, down 139.6% quarter-over-quarter from $2.9 million in Q4 2025, and up 2.51% on a YoY basis from -$1.1 million in Q1 2025.

Surrozen (SRZN) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Surrozen's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 2.51% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at $2.5 million (up 152.54% YoY), while the FY2025 annual figure was $2.5 million, up 137.03% from the prior year.
  • Change in Accured Expenses was -$1.2 million for Q1 2026 at Surrozen, down from $2.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q4 2025 to a low of -$3.8 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged -$113882.4 across 5 years, with a median of $178000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses slumped 310.11% in 2022, then jumped 810.81% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $651000.0 in 2022, then plunged by 72.66% to $178000.0 in 2023, then soared by 385.39% to $864000.0 in 2024, then surged by 239.93% to $2.9 million in 2025, then sank by 139.6% to -$1.2 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$1.2 million (Q1 2026), $2.9 million (Q4 2025), and $555000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 931,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 70.50 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - -1.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.16 Mn
Mar 31, 2026 -1.16 Mn
Dec 31, 2025 2.94 Mn
Dec 31, 2025 2.94 Mn
Sep 30, 2025 555,000.00
Sep 30, 2025 555,000.00
Jun 30, 2025 204,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 -1.19 Mn
Mar 31, 2025 -1.19 Mn
Dec 31, 2024 864,000.00
Dec 31, 2024 864,000.00
Sep 30, 2024 674,000.00
Sep 30, 2024 674,000.00
Jun 30, 2024 658,000.00
Jun 30, 2024 658,000.00
Mar 31, 2024 -1.14 Mn
Mar 31, 2024 -1.14 Mn
Dec 31, 2023 178,000.00
Dec 31, 2023 178,000.00